(ATN) Anal Cancer Study in San Francisco

DonateNow
Print this article

(ATN) Anal Cancer Study in San Francisco

AIDS TREATMENT NEWS #139, November 22, 1991
Denny Smith


Because immunosuppressed men may be at higher risk for anal cancer than those with intact immune systems, The University of California San Francisco and the San Francisco Men's Health Study are initiating a study of anal neoplasia (also called dysplasia or precancerous formations) in men with HIV infection. Pap smears will be taken periodically to observe any precancerous changes in anal tissues. The removal of those cells can halt progression to cancer.

The study is now recruiting, and interested persons may call Joel Palefsky, M. D., at 415/476-1574. Men who are seronegative will also be recruited, as a control group. Dr. Palefsky told us that Pap smears are abnormal in about 40% of HIV+ men, and a high proportion of those may go on to develop cancer if not treated. This study is a good opportunity to be monitored for this potential problem.

A related concern in women with HIV is the increased incidence of neoplasia of the cervix. For that reason, many clinicians recommend six-month, instead of yearly, Pap smears for HIV+ women. Dr. Palefsky noted that women may also want to ask for an anal Pap smear when they get their regular cervical Pap smears.

For both men and women with HIV, regular Pap smears are important for timely diagnosis and treatment of anal or cervical neoplasia.


911122
ATN13905


Copyright © 1991 - AIDS Treatment News. Permission granted for noncommercial reproduction, provided that our address and phone number are included if more than short quotations are used. Subscription lists are kept confidential. AIDS Treatment News, Subscription and Editorial Office: 1233 Locust St., 5th floor Philadelphia, PA 19107 800/TREAT-1-2 toll-free email: aidsnews@critpath.org  http://www.aidsnews.org

Subscription Information: Call 800/TREAT-1-2: Businesses, Institutions, Professionals: $270/year. Includes early delivery of an extra copy by email. Nonprofit organizations: $135/year. Includes early delivery of an extra copy by email. Individuals: $120/year, or $70 for six months. Special discount for persons with financial difficulties: $54/year, or $30 for six months. If you cannot afford a subscription, please write or call. Outside North, Central, or South America, add air mail postage: $20/year, $10 for six months. Back issues available. Fax subscriptions, bulk rates, and multiple subscriptions are available; contact our office for details. Please send U.S. funds: personal check or bank draft, international postal money order, or travelers checks. VISA, Mastercard, and purchase orders also accepted. ISSN # 1052-4207

AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 1991. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1991. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .